Ultragenyx
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $207,000 | $159,933 | $166,496 | $139,292 |
Gross Profit | 178,000 | 131,942 | 143,494 | 110,630 |
EBITDA | -105,215 | -156,786 | -91,344 | -126,438 |
EBIT | -114,000 | -165,392 | -99,963 | -135,428 |
Net Income | -129,000 | -180,413 | -114,951 | -151,080 |
Net Change In Cash | 207,000 | 159,933 | 166,496 | 139,292 |
Free Cash Flow | -100,767 | -92,701 | -95,733 | -182,799 |
Cash | 434,000 | 212,336 | 166,106 | 127,055 |
Basic Shares | 99,900 | 99,771 | 98,460 | 96,288 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $673,000 | $560,230 | $434,249 | $363,329 |
Gross Profit | 564,000 | 483,502 | 389,040 | 335,009 |
EBITDA | -500,000 | -469,002 | -516,454 | -640,490 |
EBIT | -535,000 | -504,545 | -542,460 | -658,710 |
Net Income | -575,000 | -569,183 | -606,639 | -707,421 |
Net Change In Cash | 673,000 | 560,230 | 434,249 | 363,329 |
Cost of Revenue | -170,909 | |||
Free Cash Flow | -472,000 | -421,679 | -521,573 | -526,588 |
Cash | 434,000 | 173,729 | 213,584 | 132,944 |
Basic Shares | 98,600 | 90,538 | 73,543 | 69,914 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$1.29 |
2025-09-30 | -$1.81 |
2025-06-30 | -$1.17 |
